导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 30.53% | 132/1050 |
| 近一周 | -3.75% | 934/1104 |
| 近一月 | -7.87% | 907/1102 |
| 近一季 | -17.96% | 921/1092 |
| 近半年 | 32.06% | 60/1070 |
| 近一年 | 52.63% | 67/1018 |
| 近两年 | 207.35% | 48/926 |
| 近三年 | 219.36% | 14/834 |
| 成立以来 | 226.04% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.76% 543/1070 |
80.61% 104/1101 |
- - |
- - |
| 2025 | 77.40% 48/1065 |
8.44% 204/1014 |
-2.55% 868/1038 |
53.08% 68/1050 |
9.67% 52/1065 |
| 2024 | 26.36% 40/1011 |
-0.90% 362/960 |
4.76% 101/983 |
11.91% 461/991 |
8.75% 75/1011 |
| 2023 | 1.14% 84/952 |
1.96% 513/880 |
6.38% 29/895 |
-13.96% 745/915 |
8.38% 11/952 |
| 2022 | -29.13% 600/867 |
-22.13% 643/773 |
6.05% 456/806 |
-12.98% 461/845 |
-1.38% 505/867 |
| 2021 | -0.79% 361/740 |
-5.27% 349/580 |
6.86% 431/659 |
-7.05% 416/704 |
5.44% 207/740 |
| 2020 | 30.44% 345/554 |
-6.81% 337/419 |
14.61% 359/466 |
11.49% 217/517 |
9.55% 372/554 |
| 2019 | 30.84% 284/410 |
24.71% 722/1149 |
-1.21% 459/1231 |
1.50% 290/390 |
4.64% 349/410 |
| 2018 | -21.71% 99/349 |
- - |
- - |
- - |
-12.69% 688/1080 |
| 2017 | 24.18% 70/285 |
- - |
- - |
- - |
- - |
| 2016 | -17.58% 104/205 |
- - |
- - |
- - |
- - |
| 2015 | 38.79% 39/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城研究精选股票A VS. 东吴新产业精选股票A(580008) |